Table 1.
Clinical characteristics and treatment of this patient.
| Time | Menstrual cycle | Size of ovary*(cm) | Hormones (reference values) | Examinations | Medication | Treatment | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| FSH (IU/L)Fp 3.5-11.5 mc 4.7-21.5 lp 1.7-7.7 | LH (IU/L)Fp 2.4-12.6 mc 14-95.6 lp 1.0-11.4 | E2 (ng/L)Fp 12.4-233 mc 41-398 lp 22.3-341 | P4 (μg/L)Fp 0.2-1.5 mc 0.8-3.0 lp 1.7-27 | T (nmol/L)(0.19-1.67) | PRL (μg/L)(4.79-23.3) | ||||||
| 2012.03 | – | 87 | – | – | – | – | – | – | Ovarian cystectomy | ||
| 2013.01 | – | 92 | – | – | – | – | – | – | Ovarian cystectomy | ||
| 2014.05 | 60 | 89 | 11.05 | 0.10 | 979.9 | 7.87 | 0.19 | – | CA125 (-) CA199 (-) |
E+P OC1 |
|
| 2014.07 | 12 | 85 | 10.92 | 0.10 | 230.3 | 3.19 | 0.18 | 23.54 | GnRH-a | ||
| 2014.08 | 11 | 97 | 10.77 | 0.10 | 975.2 | 6.67 | 0.27 | 30.98 | Ovarian cyst puncture | ||
| 2014.09 | 3 | 67 | 10.51 | 0.10 | 252.0 | 3.71 | 0.33 | 17.35 | Adrenal ultrasonography | ||
| 2014.11 | 8 | 83 | 12.24 | 0.10 | 997.1 | 5.01 | 0.30 | 52.48 | MRI | Transsphenoidal surgery | |
| 2017.03 | 17 | 91 | 13.50 | 0.20 | 1781.0 | 8.3 | 0.89 | 24.1 | MRI | Gamma knife | |
| 2017.07 | 3 | 78 | 7.80 | 0.10 | 336.3 | 7.5 | 1.46 | 42.8 | B OC2 |
||
| 2017.08 | 5 | 65 | 3.00 | 0.10 | 62.9 | 0.5 | 0.46 | 0.5 | B OC2 |
||
*A major axis; fp, follicular phase; mc, mid-cycle; lp, luteal phase (in premenopausal women); E, ethinyl oestradiol; P, dydrogesterone; OC1, 0.15 mg desogestrel+30 μg ethinyl oestradiol; B, bromocriptine; OC2, 2 mg cyproterone acetate+0.035 mg ethinyloestradiol.